Intra-abdominal hypertension (IAH) is highly prevalent in critically ill patients admitted to the intensive care unit and is associated with an increased morbidity and mortality. The present study investigated whether femoral venous pressure (FVP) can be used as a surrogate parameter for intra-abdominal pressure (IAP) measured via the bladder in IAH grade II (IAP <20 mmHg) or grade III (IAP ≥20 mmHg). This was a single-centre prospective study carried out in a tertiary adult intensive care unit. IAP was measured via the bladder with a urinary catheter with simultaneous recording of the FVP via a femoral central line. If the IAP was <20 mmHg external weight to a maximum of 10 kg was applied to the abdomen with subsequent measurements of IAP and FVP. Eleven patients were enrolled into the study. IAH (IAP >12 mmHg) was identified in five patients (42%) and abdominal compartment syndrome (ACS, IAP >20 mmHg with new onset organ failure) in two (18%) with all-cause study mortality of 18%. The mean Acute Physiology and Chronic Health Evaluation (APACHE) II score was 21 ± 5, Simplified Acute Physiology (SAPS 2) score 49 ± 8, and Sequential Organ Failure Assessment (SOFA) score 9 ± 3. At baseline the bias between IAP and FVP was 3.2 with a precision of 3.63 mmHg (limits of agreement [LA] -4.1, 10.4). At 5 kg and 10 kg, the bias was 2.5 with a precision of 3.92 mmHg 10 .3) and 2.26 mmHg (LA -2.1, 7.0) respectively. A receiver operating characteristic analysis for FVP to predict IAH showed an area under the curve of 0.87 (95% confidence interval 0.74-0.94, P=0.0001). FVP cannot be recommended as a surrogate measure for IAP even at IAP values above 20 mmHg. However, an elevated FVP was a good predictor of IAH.
Introduction
Intra-abdominal hypertension (IAH) is defined as an intra-abdominal pressure (IAP) ≥12 mmHg and abdominal compartment syndrome (ACS) as a sustained IAP >20 mmHg that is associated with a new organ dysfunction/failure [1] [2] [3] . IAH has a high prevalence in critically ill patients admitted to the intensive care unit (ICU), reported as around 58.8% within the first week of ICU stay 4 , and is associated with increased morbidity and mortality 5 .
Central venous access is commonplace in intensive care to allow administration of drugs, monitoring of central venous pressures, and sampling of venous oxygen saturations 6 . It is routinely placed within the internal jugular or subclavian vein, but when there is a high risk of complications the femoral route is often used 7, 8 . Using femoral venous pressure (FVP) as a surrogate marker for IAP may help in the recognition of ACS in the early stages of a patient's admission to the ICU and may eventually decrease morbidity and improve mortality. An instituted IAH/ACS management algorithm has been shown to improve patient survival to hospital discharge (from 50% to 72%) 9 .
A common concern with measuring the IAP via the intravesical route is the intermittent timing of readings, usually at intervals of 4-6 hours as recommended by the World Society of Abdominal Compartment Syndrome (WSACS) 1 . There is an advantage to being able to diagnose IAH grade II (IAP 15-20 mmHg) or III (IAP >20 mmHg) or ACS in those critically ill patients at risk earlier through continuous monitoring 10, 11 . IAP can be continuously monitored either through the intravesical route with a three-way catheter 12 or via the intragastric route with a balloon-tipped catheter 13 .
There is conflicting data on whether FVP is comparable to or interchangeable with IAP measured via the standard intravesical technique [14] [15] [16] [17] [18] . In an animal model, Regli et al 19 was able to demonstrate good correlation between IAP and FVP but there seem to be difficulties transferring this into the human population. Markou et al 20 looked at IAP versus central venous pressure (CVP) via the inferior vena cava in mechanically ventilated patients. They found that pressures measured in the inferior vena cava reflected IAP values measured via the bladder. However this was only the case when bladder pressures exceeded 15 mmHg (18.8 ± 0.69 versus 19.18 ± 0.63 mmHg, P <0.01) but not when bladder pressures were below 15 mmHg (14.6 ± 0.58 versus 11.4 ± 0.2, P <0.05). In a multicentre prospective observational trial, De Keulenaer et al 21 only found good correlation when the IAP was greater than 20 mmHg with large limits of agreement (LA). A FVP equal to 14.5 mmHg predicted an IAP above 20 mmHg with a sensitivity and specificity of 91.3% and 68.1% respectively. Although IAP measurements were standardised there might still have been some variation due to the multicentre nature. This could be minimised by reduction in personnel performing the measurements with a robust repeatable measurement protocol.
The main aim of this pilot study was to determine if IAP measured via the intravesical route was equal or similar to FVP in conditions where IAP was equal to or greater than 20 mmHg in the critically ill population. A secondary outcome was to look at the safety of the method, only described once before, of placing external weight onto the abdomen to artificially raise IAP 22 . Thirdly, by improving standardised measurements with fewer investigators would this improve the level of agreement between the two measurements?
Materials and methods

Study design
This study was designed as a prospective single-centre pilot trial comparing IAP measurements via the bladder with FVP at baseline and with artificially increased IAP ≥20 mmHg. The study was approved by the South Metropolitan Health Service Human Research Ethics Committee (protocol: 10/533).
Patient selection
Patients were enrolled into the trial between April 2011 and November 2012. Patients were included only if they had a pre-existing femoral venous catheter and indwelling bladder catheter, and if they were aged at least 18 years, mechanically ventilated and sedated, so that treatment did not deviate from standard care. Patients were excluded if they were unable to tolerate changes in body position (supine position) due to spinal injury, intracranial hypertension or for any other reason, if they were moribund (death perceived to be imminent or inevitable during the next month), pregnant, or had an open abdomen. Written informed consent was obtained from patients' next of kin.
Protocol
Once the patient was enrolled, IAP was measured according to the WSACS consensus recommendations using the standard bladder technique 1 . The IAP was measured through the patient's indwelling catheter, according to the modified Kron technique using an AbViser 300 or 611-kit (Convatec Medical, Greensboro, NC, USA, formerly provided by Wolfe-Tory Medical, Salt Lake City, UT, USA) 22 . The transducers for IAP and FVP were zeroed at the level of the superior iliac crest where the mid-axillary line crosses the iliac crest 23, 24 . The pressure transducers were placed into a specially engineered transducer device (Fremantle Hospital Medical Equipment Department, Fremantle, WA, see Figure 1 ) and then connected to the electronic monitoring equipment (Philips IntelliVue MP40, Philips Healthcare, North Ryde, NSW).
After zeroing, the pressure was measured at end-expiration in mmHg at the same time as the IAP measurement. For IAP measurement, 20 ml of sterile saline was injected into the bladder through the indwelling catheter; IAP was measured approximately 30 seconds later at end-expiration in mmHg. End-expiratory diastolic and mean venous pressures were recorded using the FVP measurement set to pulmonary artery pressure (PAP) and using the wedge pressure waveform application on the monitor. To reduce interobserver variability, IAP and FVP measurements were limited to three investigators.
If the baseline IAP measurement was >20 mmHg, no external weight was placed onto the patient's abdomen and the procedure was repeated for the second set of measurements no less than two hours, and no more than 24 hours later (see Figure 2 ).
If the first IAP was <20 mmHg, further measurements were obtained after placement of an external weight of 5 kg or more (maximum 10 kg) onto the patient's abdomen. One to two 5 litre bags of dialysate (Accusol 35 solution for haemofiltration, Baxter Healthcare, NSW) were placed in the centre of the abdomen directly over the umbilicus in a horizontal orientation (see Figures 3 and 4 ). The weight was left for three minutes to monitor for cardiovascular and respiratory deterioration as well as to enable equilibration of IAP to occur.
The IAP and FVP measurements were repeated with 5 kg weight as described above and recorded. If the IAP remained below 20 mmHg with the 5 kg external weight, the measurements were repeated with 10 kg weight as described above, and IAP and FVP were recorded. The same process was followed for the second set of measurements no less than two hours, and no more than 24 hours later.
When an external weight was applied, careful monitoring was made of both the cardiovascular and respiratory systems. If any of the following occurred, the external weight would be removed and the measurements abandoned and documented: a drop in mean arterial pressure to less than 60 mmHg, a drop in saturation to values below 90%, a drop in tidal volume by 50% or more (or to less than 200 ml), or a peak airway pressure of more than 40 cmH 2 O.
Data Collection
Patient demographic data was collected, including height, weight, calculated body mass index (BMI), age, gender, significant comorbidities, ICU admission diagnosis as well as the type of venous access (number of lumens), site of insertion, and complications of femoral central venous access. Severity of illness using the Acute Physiology and Chronic Health Evaluation (APACHE) II score as well as the Simplified Acute Physiology Score (SAPS) and Sequential Organ Failure Assessment (SOFA) score during the 24-hour period before the first IAP measurement was recorded. With each set of measurements, IAP, FVP, mean arterial pressure, positive end-expiratory pressure, temperature, and Richmond Agitation Sedation Score (RASS) were recorded. Pressure sets were measured in each patient twice at least two hours and no more than 24 hours apart. At the conclusion of the study, data on patient survival to ICU discharge was collected in combination with data on femoral line complications with relevant microbiology.
IAH was defined by an IAP ≥12 mmHg and further divided by the agreed WSACS grading; Grade I: IAP 12-15 mmHg,  Grade II: IAP 16-20 mmHg, Grade III: IAP 21-25 mmHg and  Grade IV: IAP >25 mmHg. All data was entered onto a predesigned case report form and subsequently entered into a Microsoft Excel statistical coding document.
Statistical analysis
Statistical analysis was performed using the STATA 13.0 (College Station, TX, USA). Data is presented as mean ± standard deviation (SD). Paired Student's t-tests were used to test statistical significance between IAP and FVP measures within the same patient at the same time. Significance level of P <0.05 was used throughout. To assess the level of agreement between the two methods of measurement of IAP we used the Pearson correlation coefficient and Bland-Altman plots (with calculation of bias, precision and LA) and finally, to test variance we used Pitman's test of difference. A receiver operating characteristic (ROC) curve was created to evaluate the diagnostic capacity of FVP in detecting IAH (IAP >12 mmHg).
Results
Patient demographics
A total of 11 patients were enrolled with a total of 53 paired IAP/FVP measurements. Patient demographics and severity of illness scores are presented in Table 1 . There was one patient (9%) with surgical admission and one patient (9%) with trauma.
All other patients were medical admissions (82%) and all patients were non-elective admissions into the ICU. IAH (Grade I and above) was identified in five patients (42%) with only two patients (18%) having evidence of ACS. The overall mortality was 18% (two patients died, both had IAH but no evidence of ACS).
Three patients out of the 11 (27%) did not have complete sets of measurements performed. One patient (9%) had no secondary measurements due to a change in prognosis and the patient died a short time later after palliation. Two patients (18%) had limited measurements due to apparent discomfort on application of the external weight for both the first and second measurement sets. There was no abandonment of measurement due to adverse changes in cardiovascular or respiratory parameters. There was no statistical difference found when using endexpiratory diastolic FVP versus end-expiratory mean FVP as the comparison with IAP. As the mean pressure value for central venous pressure recording is the most accepted approach in the critically ill setting, we decided to only use mean FVP in our comparison results.
IAP and FVP comparison
The bias, precision, LA, Spearman rank correlation coefficient, and coefficient of determination (R 2 ) were calculated for all measurements. This is shown in Table 2 and in Figures 5 and 6. The pooled mean IAP was 13.1 ± 5.5 mmHg versus 15.9 ± 4.2 mmHg for FVP and the bias was 2.8 (LA -4.1, 9.6). The coefficient of determination was significant (R 2 0.61, P <0.01). At 0 kg of weight the bias between IAP and FVP was 3.2 with a precision of 3.63 mmHg (LA -4.1, 10.4). At 5 kg and 10 kg, the bias was 2.5 with a precision of 3.92 mmHg (LA -5.4, 10.3) and 2.26 mmHg (LA -2.1, 7.0) respectively.
Change in IAP with the addition of weight
With the addition of 5 kg the IAP increased by 3.7 mmHg (SD 2.0) and with the addition of 10 kg, IAP increased by 6 mmHg (SD 2.2). Overall the pooled mean change was 3.9 ± 1.9 mmHg with a bias of -1.4 and precision of 1.7 mmHg (LA -4.8, 1.9) (see Figure 7 ).
FVP to predict IAP
Univariate linear regression of prediction of IAP based on mean FVP showed that FVP was significantly correlated with IAP but the confidence interval was wide (P=0.003 and CI 0.5-2.0, correlation coefficient 0.8, strong correlation between FVP and IAP). At the highest weight of 10 kg, percentage error (PE) was at its lowest compared with baseline (27.1% versus 56.7%). Concordance analysis for the whole group was 96.7% (32/33).
To predict IAP ≥12 mmHg, ROC analysis for FVP showed an area under the curve of 0.87 (95% CI 0.74-0.94), P=0.0001. The best threshold was an FVP of >17 mmHg with a 63.6% (45.1%-79.6%) sensitivity and a 95.0% (75.1%-99.2%) specificity (Figure 8 ).
Discussion
The main findings of this single centre study are in accordance with previous results published by De Keulenaer et al 21 indicating that FVP cannot be used as a surrogate measurement for IAP due to large limits of agreement. However the 10 kg measurements with mean IAP/FVP 16.7 ± 3.8 mmHg had the lowest percentage error suggesting that interchangeability is best at highest weight or thus at higher IAP values. This means that changes in FVP could be used to predict and track changes in IAP. For two IAP techniques to be considered interchangeable the WSACS has recommended strict guidelines of bias less than 1 mmHg, precision of 2 mmHg and/or limits of agreement between -4 and 4 mmHg 26 . In our study, despite good correlation and reasonable precision, the limits of agreement were too large to consider both techniques equivalent. Our results with measurements performed only by three investigators suggest that the large limits of agreement are less likely due to inter-observer variability.
The principle of using a fluid medium (e.g. urine, blood) as a coupler between the area of interest (abdominal compartment, arterial or venous pressure) and the transducer is common in medicine.
Bladder pressure is recommended by the WSACS as the clinical gold standard 1, 3, 27 . Despite being an indirect measurement of IAP, bladder pressure correlates well with direct IAP measurements and has an acceptable limit of agreement between bladder pressure and direct IAP measurements. It is reproducible and is easy and safe to perform at the bedside in clinical practice. It is also the most frequently quoted method for IAP measurement used in clinical studies. It is assumed that IAP in critically ill patients is chiefly influenced by uniform compression in a sphere and to a smaller degree by gravity. As a hydraulic system the abdomen can transmit IAP to the retroperitoneal bladder. In theory, the abdomen should also be able to transmit IAP to the intra-abdominal veins. So a catheter inserted into the femoral vein with the tip positioned in the external or common iliac vein should be able to measure IAP. Differences between IAP and FVP have been shown in animal 19 and in human subjects 28 and are not fully understood. In an animal study FVP was shown to parallel CVP in the absence of IAH but to parallel IAH when present. Positive end-expiratory pressure (PEEP) has been shown to influence FVP in the absence of IAH but not in the presence of IAH 19 . The mean circulatory filling pressure as described by Guyton has been suggested to explain why FVP measures higher than the bladder pressure 29 .
Although our results are consistent with previous studies in concluding that FVP cannot be used as a surrogate measurement of IAP we still think FVP measurement can provide important clinical information. FVP provides continuous readings. Sudden increases in FVP are likely to be paralleled by increases in IAP. We found that elevated FVP (>17 mmHg) was associated with IAH. Therefore elevated FVP should trigger assessment of IAP via bladder pressure especially in patients at risk of developing IAH/ACS.
Medical and nursing staff should be educated that FVP correlates well with CVP in the absence of IAH, but that high FVP might indicate that IAH is present and should trigger measurement of bladder pressure.
The criticism of IAP measurement via the intravesical route is the intermittent nature of the measurements. It has been long been argued that 4-6 hours between measurements may be too long and lead to adverse outcomes. There has been an interest to develop a method to continuously measure IAP. The routine use of a three-way catheter that allows continuous IAP monitoring has been poorly validated and not widely accepted 30, 31 . This is due to the increased cost as well as the risk of underestimating the IAP due to continuous drainage of urine and the negative suction forces that are created 21 .
We found that the application of external weight to the abdomen did not cause any negative effect on the cardiorespiratory system in our critically ill cohort of patients. The main reason to interrupt adding further weight application to the abdomen was discomfort in two patients (18%) of the trial group. When reviewed, one patient had a RASS of 0 during both sets of measurements and could not support the 10 kg weight placement. The other patient had a RASS of -4 but on the second set of readings was noted to be in pain with an increase in respiratory rate (with stable respiratory function) so the study was discontinued before placement of 10 kg.
The technique of external application of weight that we used in our trial has only been described once by Citerio et al 22 . They applied a soft 15 litre bag of water over the abdomen, avoiding the ribs and hips, looking at changes in IAP, lung and chest wall compliance and intracranial pressure.
Its application in future trials could be safely used to look at the effects of raised IAP in sedated ICU patients. Regli et al 32 looked at optimal PEEP in a ventilated porcine sick lung model with raised IAP. The IAP increase was created with the use of a large intra-abdominal latex balloon that was inflated/ deflated to the required IAP. They found that matching PEEP to IAP led to a statistically significant increase in lung volumes and oxygenation, with a decrease in chest wall elastance, shunt and dead space. There was difficulty in transferring this technique into the human setting but with the described technique of external weight application there is now a safe, ethically approved and reproducible method to artificially increase IAP for research in critically ill patients.
The mean change in IAP by adding 5 and 10 kg was small, and of limited clinical significance. This is an important point to bear in mind as increasing the external weight applied to the abdomen beyond 10 kg may not be feasible and would lead to increasing patient discomfort.
Limitations
There were several limitations to this trial. The first was noted in the trial by De Keulenaer et al 21 , with both IAP via the bladder and FVP being indirect measurements, and comparing the two techniques can confound the precision and bias in the results. We attempted to overcome interobserver variability by limiting the number of investigators able to perform the measurements. This led to a smaller number of participants enrolled due to a lack of investigator presence.
Another limitation was the proposed application of external weight onto a critically unwell patient. Despite the trial being rigorously examined by the local ethics committee there was reluctance not only from consenting family members but also from intensive care staff concerned that this may induce harm to the patient. Our trial revealed no direct adverse outcomes, but this could also explain the limited number of participants willing to consent.
Conclusions
From this limited study FVP cannot be recommended as a surrogate measure for IAP measurement via the bladder even at IAP >20 mmHg. FVP >17 mmHg was a predictor of IAH and may be used as a continuous screening tool if a femoral venous catheter has already been placed for venous access.
Due to the small number of participants and the relative safety of short-term placement of femoral venous catheters, a larger trial would be warranted to confirm these results.
